Correction to: White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab

J Neurooncol. 2019 Dec;145(3):467. doi: 10.1007/s11060-019-03346-1.

Fayez Estephan¹, Xiaobu Ye^{1

2}, Omar Dzaye^{1

3

4}, Nina Wagner-Johnston¹, Lode Swinnen¹, Douglas E Gladstone¹, Rich Ambinder¹, David Olayinka Kamson¹, Sebastian Lambrecht³, Stuart A Grossman¹, Doris D M Lin^{5

6}, Matthias Holdhoff^{7

8}

¹ The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
² Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
³ Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁴ Department of Radiology and Neuroradiology, Charité, Berlin, Germany.
⁵ Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA. ddmlin@jhmi.edu.
⁶ Division of Neuroradiology, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD, 21287, USA. ddmlin@jhmi.edu.
⁷ The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. mholdho1@jhmi.edu.
⁸ The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Viragh Building, 9th floor, 201 North Broadway, Mailbox 3, Baltimore, MD, 21287, USA. mholdho1@jhmi.edu.

Abstract

The following discrepancies and errors were found in the original publication.